Convergence Investment Partners LLC Purchases Shares of 14,189 American Healthcare REIT, Inc. $AHR

Convergence Investment Partners LLC purchased a new stake in American Healthcare REIT, Inc. (NYSE:AHR) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 14,189 shares of the company’s stock, valued at approximately $521,000.

Other large investors also recently bought and sold shares of the company. Stratos Wealth Partners LTD. lifted its holdings in American Healthcare REIT by 57.9% in the first quarter. Stratos Wealth Partners LTD. now owns 16,070 shares of the company’s stock valued at $487,000 after acquiring an additional 5,891 shares during the period. GAMMA Investing LLC lifted its holdings in American Healthcare REIT by 42.2% in the first quarter. GAMMA Investing LLC now owns 1,405 shares of the company’s stock valued at $43,000 after acquiring an additional 417 shares during the period. Envestnet Portfolio Solutions Inc. acquired a new position in American Healthcare REIT in the second quarter valued at approximately $207,000. Sequoia Financial Advisors LLC acquired a new position in American Healthcare REIT in the first quarter valued at approximately $476,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in American Healthcare REIT by 4.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,235,051 shares of the company’s stock valued at $67,722,000 after acquiring an additional 89,926 shares during the period. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Stock Up 0.4%

Shares of AHR opened at $44.50 on Tuesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48. American Healthcare REIT, Inc. has a one year low of $24.21 and a one year high of $44.81. The stock has a market capitalization of $7.50 billion, a price-to-earnings ratio of -202.25, a PEG ratio of 2.21 and a beta of 0.98. The stock has a 50 day moving average price of $42.26 and a 200 day moving average price of $37.82.

American Healthcare REIT (NYSE:AHR) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The firm had revenue of $542.50 million during the quarter, compared to analysts’ expectations of $539.49 million. During the same period in the previous year, the business earned $0.33 earnings per share. The firm’s revenue for the quarter was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Equities research analysts forecast that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Tuesday, September 30th. American Healthcare REIT’s payout ratio is presently -454.55%.

Insider Activity at American Healthcare REIT

In related news, EVP Mark E. Foster sold 3,850 shares of the business’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the sale, the executive vice president directly owned 59,100 shares in the company, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on AHR shares. UBS Group started coverage on American Healthcare REIT in a report on Friday, September 19th. They issued a “buy” rating and a $51.00 price target for the company. Baird R W raised American Healthcare REIT to a “strong-buy” rating in a research note on Thursday, July 17th. KeyCorp upped their target price on American Healthcare REIT from $40.00 to $43.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 14th. Scotiabank reaffirmed an “outperform” rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Finally, Royal Bank Of Canada upped their target price on American Healthcare REIT from $39.00 to $45.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, American Healthcare REIT presently has an average rating of “Buy” and a consensus price target of $45.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.